Related Experiment Video
Updated: Oct 16, 2025

06:45
Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
2.5K
Deep-AFPpred: identifying novel antifungal peptides using pretrained embeddings from seq2vec with 1DCNN-BiLSTM
Ritesh Sharma1, Sameer Shrivastava2, Sanjay Kumar Singh1
1Department of Computer Science and Engineering, Indian Institute of Technology (BHU), Varanasi, 221005, Uttar Pradesh, India.
Briefings in Bioinformatics
|October 20, 2021
Summary
A new deep learning model, Deep-AFPpred, efficiently identifies antifungal peptides (AFPs) in protein sequences. This tool aids in discovering novel antifungal molecules to combat rising drug resistance and infections.
Area of Science:
- Bioinformatics
- Computational Biology
- Mycology
Background:
- Fungal infections (mycoses) are increasing, exacerbated by COVID-19 and rising antifungal resistance.
- Limited therapeutic options necessitate the search for novel antifungal molecules.
- Antifungal peptides (AFPs) show promise, but natural source identification is costly and slow.
Purpose of the Study:
- To develop a robust in silico model for identifying novel antifungal peptides (AFPs) in protein sequences.
- To create an accessible online prediction server for AFP discovery.
Main Methods:
- Developed Deep-AFPpred, a deep learning classifier using transfer learning with a 1DCNN-BiLSTM algorithm.
- Trained and validated the model on protein sequences to predict AFPs.
- Created a publicly available online server for AFP prediction.
Main Results:
- Deep-AFPpred significantly outperforms existing state-of-the-art AFP classifiers.
- Achieved high precision: approximately 96% on validation data and 94% on test data.
- The online server provides predicted peptides, physicochemical properties, and motifs.
Conclusions:
- Deep-AFPpred offers an efficient and accurate method for identifying novel AFPs.
- The developed online tool facilitates the discovery of potential antifungal agents.
- Identified AFPs can be synthesized and experimentally validated, advancing antifungal drug development.

